APRIL 22, 2022 | EYEWORLD DAILY NEWS | 9
ASCRS ANNUAL MEETING
DAILY NEWS
"We're trying to hone the program
to keep what seems to be exciting for
the attendees and evolve other topics
to keep it fresh," Dr. Mah said.
"We have put together an excellent
Cornea Day program this year that
covers a spectrum of topics that will
interest both the cornea specialist as
well as comprehensive doctors who
treat office-based corneal disease," said
Program Chair Marjan Farid, MD. The
program will also feature a govern-
ment relations presentation from Parag
Parekh, MD.
"We are looking forward to a great
day of education and comradery," Dr.
Farid said.
P
rogram Chair Francis Mah, MD,
said that the 2022 Cornea Day
program seeks to "hone-in on
what attendees enjoy about
Cornea Day." One of the unique aspects
is that it's the ASCRS Cornea Clinical
Committee directing, moderating, and
formulating the entire program with
the best educators and presenters from
around the world participating, Dr.
Mah said.
This year, Cornea Day will have
four sections, focusing on management
of keratoconus and corneal ectasia,
anterior/posterior lamellar surgery, the
ocular surface, and challenging corneal
cases.
The first section, covering updates
in management of keratoconus and
corneal ectasia, will be moderated
by Ken Beckman, MD, and Zachary
Zavodni, MD. Crosslinking will be cov-
ered, and other presentations will focus
on INTACS, topography-guided PRK,
scleral lenses, and genetic testing.
The second section of the pro-
gram will focus on anterior/posterior
lamellar surgery, primarily DMEK
and DSAEK. "This has always been a
popular subject for the clinical corneal
specialists," Dr. Mah said. Presentations
on DALK and DSO/DWEK will also be
included.
"The ocular surface remains a
very important topic," Dr. Mah said.
"This ranges from the core dry eye and
co-conspirators to more difficult issues
like neurotrophic keratitis and severe
ocular surface disease with various ap-
proaches, which are more involved and
need teams and tertiary care."
The last section will focus on
challenging corneal cases, which Dr.
Mah said was popular on last year's
program. This will include infections,
inflammation, and tumors.
A look at the 2022 Cornea Day
Discover
the DURYSTA
®
Difference
Visit Allergan
®
booth 2215
for more information
Not actual DURYSTA
®
patients.
Models for illustrative purposes only.
© 2022 AbbVie. All rights reserved.
All trademarks are the property of their respective owners.
US-DUR-220059 03/2022 015922
